Private practice with Dr Seth Bilazarian

View all posts »

The unfortunate side effects of the industry/physician breakup

Jun 16, 2010 14:20 EDT


Aggressive efforts to limit industry relationships with physicians have had the unfortunate side effect of wiping out numerous educational opportunities in my area, where community-based programs that facilitated discussion on topics such as lipid, hypertension, and antiplatelet therapies, for instance,  no longer exist. How do we balance our need for fair and appropriate education with the perception that all physician-industry relations are necessarily "bad"? What are your thoughts?

See:

Gelberman RH, Samson D, et al. Orthopaedic surgeons and the medical device industry: the threat to scientific integrity and the public trust. J Bone Joint Surg Am. 2010 Mar;92(3):765-77. No abstract available. PMID: 20194337.

All about ethics: The Physician Payments Sunshine Act

Rothman DJ, McDonald WJ, et al. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA. 2009 Apr 1;301(13):1367-72. Abstract.

Peeling the onion: Is more conflict of interest disclosure getting us closer to the truth?
[Heartwire > Features; Apr 24, 2009]








Your comments
The unfortunate side effects of the industry/physician breakup
# 1 of 5
June 18, 2010 08:19 (EDT)
Boston Interventional Cardiologist
Seth, I agree. The loss of educational opportunities is indeed an unfortunate side effect. Unfortunately it is the actions of a minority of Physicians that mandate such "drastic" limitations to be imposed on us all.  Your experience at Lahey Clinic is a great example of this - The scandal of the Cath Lab Director accused of inappropriate financial and personal ties with Medtronic.  The lack of any internal discipline and the culture of cover-up at that Clinic despite an ongoing Federal investigation is evidence enough as to why the State has to mandate what is appropriate and to set limits on industry-physician relationships.
# 2 of 5
June 19, 2010 04:04 (EDT)
NY Researcher

There is nothing new in the restrictions, or the reasons for them.  40 years ago it was pharmaceutical companies (still is), now it is device manufactuerers.  It is also no different from corporate buyers who accept freebies from suppliers, who send the 'gift' to their homes.  Or federal employees who recommend air tankers in exchange for a lucrative position afterwards.

Federal employees are forbidden from accepting meals (or even coffee) on a one-to-one basis from suppliers.  I have seen a laboratory director  refuse to let a marketing rep add a bag of chips to the rep's lunch tab.  Integrity (and the lack thereof) is evenly spread across society.  When internal controls work, outside imposition of restrictions will not be needed.

# 3 of 5
June 28, 2010 08:59 (EDT)
Frederic G Jones, MD FACC FACPE

I was Chief Medical Officer for a 500 bed comminity teaching hospital from 1978-1998. In addition, I served as director of medical education for a family practice residency and accredited hospital CME. I also served as CME program director for the County medical Society. From the beginning we created a memo of understanding about indusrty relations, and reqired compliance by the many pharmaceutical and device makers.

It turned out to be be mutually beneficial with superb national and regional speakers expanding the CME offerings of a community without medical school or academic medical center talents. A policy was developed and agreed on by all parties. There are models that seem to preserve the educational benefits of these associations without permitting undue influence.

Perhaps not a perfect solution but avoiding what appears to be an overreaction with the aforementioned unintented consequences of loss of educational opportunities and collaborative efforts from our profession and industry which all stive in the calling to patient care.

# 4 of 5
July 1, 2010 10:47 (EDT)
Boston Interventional Cardiologist

Seth- I respectfully disagree. First, to bemoan the loss of educational opportunities when industry-physician relationships are limited is wrong.  Vendors roles are to market not to educate.  The conflict is that they have a fiduciary responsibility to their shareholders not to you, your patients or public health.  Every study has that has looked at the influence of industry on MD practice patterns shows the same thing- when physicians receive perks from industry, even trivial things like free lunches, their prescribing and usage patterns change and this is usually manifested by chosing more expensive, rather than generic or cheaper options.  Trainees such as residents and fellows are specifically targeted since they form patterns early in their careers, much like McDonalds gives toys with the Happy Meal.  Industry spends billions of dollars trying to influence physician behavior.  If you speak with former reps they will tell you how much time they spend in seminars training them how to ingratiate themselves with doctors and influence them.  Unfortunately as a profession we have not policed ourselves.  All of us saw our colleagues, wined and dined, taken on golf junkets, etc.  Did we really believe this was to educate us or to seduce us? 

 Finally, no one has said we can't interact with industry and hear about their products.  But, do we really have to be fed, or compensated to be educated?

# 5 of 5
July 30, 2010 01:23 (EDT)
Frank

I do think that industry has it's own agenda...and it isn't our education.  It is to sell devices or drugs or catheters.  Even the most balanced and fair presentation  sponsored by a company will have some positive influence on our usage.  That's why these companies do it!

I am even more concerned about how researchers in a particular field become incredibly entrained with the device manufacturers.  The are on the speakers' bureau...they get the early devices for testing...they get to present the "latest and greatest" at the national meetings...and then they get to go in front of the FDA's panels and recommend that the devices be approved --- or even worse...they are on the FDA panel and they are getting to approve devices that they were "paid" to study.

 

 


You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

About Dr Seth Bilazarian
Seth Bilazarian MD has been a Clinical and Interventional Cardiologist at Pentucket Medical Associates in Massachusetts since 1993. He is board certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology, Vascular Ultrasound, Interventional Cardiology, and Vascular and Endovascular Medicine.

Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.

Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
About this blog
My intent is to create a forum for dialogue on issues pertinent to private practice cardiology around topics such as:

  • Integration of new data and guidelines on inpatient and outpatient practice in clinical and interventional cardiology
  • Practice approaches to the extra clinical issues in dealing with managed care insurers
  • Strategies for navigating the restrictions of pharmacy benefits managers (PBMs) on pharmacologic therapies for our patients
  • Experiences with restrictions on testing and imaging
The video blog (VLOG) will provide an opportunity to share broadly different approaches to the common conundrums we face in caring for patients. My hope is that this forum will provide useful data points for practice outside of tertiary and academic centers and a look inside community hospitals and physician?s practice patterns in the office, starting with mine.